The new pressure on Prime Minister Netanyahu in the midst of the Israel-Hamas Conflict.
Former Editor-in-Chief of the Jerusalem Post, Yaakov Katz, explains how mounting international and domestic pressure is influencing Israeli Prime Minister Benjamin Netanyahu’s decisions during the...
Advocacy group: 2,000+ antisemitic incidents since Hamas attacks
CNN’s Omar Jimenez looks at the recent rise in antisemitic incidents across the U.S....
Mitsubishi’s CEO on EVs and how to compete with China
CNN’s Marc Stewart takes a drive with Mitsubishi CEO Takao Kato in Tokyo to discuss the company’s future amid stiff competition from China....
Cardio and counseling: training to be a ‘superbowl’ esports athlete
CNN’s Kristie Lu Stout takes a trip to Seoul to the biggest event in the esports calendar to find out why it’s the fastest growing...
EU opens membership talks to Ukraine and Moldova
European Union leaders and Ukrainian president Volodymyr Zelensky hail discussions on Ukraine’s possible membership in the EU...
Chinese C919 jet showcased in Hong Kong
Kristie Lu Stout speaks with Geoffrey Thomas, Editor-in-Chief of Airlineratings.com about China’s homegrown C919 aircraft with the hopes of rivaling Boeing and Airbus...
CNN asked Jake Sullivan about Israel using ‘dumb bombs’ in Gaza. Hear his response
CNN’s Alex Marquardt asks National Security Adviser Jake Sullivan about Israel using “dumb bombs” in Gaza and what the United States’ stance is on this....
‘None even come close’: Collins debunks GOP senator’s fake elector claims
In a recent interview with Sen. Ron Johnson (R-WI), the lawmaker claimed the group of Wisconsin fake electors did not do anything different than what...
Erdogan’s message to Biden
Turkish President Recep Tayyip Erdogan told U.S. President Joe Biden that the United States has a historical responsibility to ensure a permanent ceasefire in Gaza,...
Experimental vaccine shows benefits against melanoma in trial
: An investigational mRNA vaccine used along with immunotherapy continues to show benefit for people with high-risk forms of the skin cancer melanoma, the drugmakers...